Ocular Therapeutix (OCUL) Share-based Compensation (2013 - 2026)
Ocular Therapeutix (OCUL) posted Share-based Compensation of $14.65 million for Q2 2026, up 51.4% from $9.68 million a year earlier but down 6.0% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Share-based Compensation (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Ocular Therapeutix was $53.28 million, up 56.8% year-over-year; for FY2025, it came in at $43.18 million, up 30.4% from FY2024.
- Annual Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 41.8% (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Share-based Compensation was $33.11 million in FY2024 (+85.7%), $17.83 million in FY2023 (+5.1%), $16.96 million in FY2022 (+13.3%) and $14.98 million in FY2021 (+98.9%).
- Quarterly Share-based Compensation has run from a low of $3.76 million in Q3 2021 to a high of $15.58 million in Q1 2026 over five years.
- On a year-over-year basis, Share-based Compensation has increased in each of the last four quarters, with growth averaging 45.6% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2024, with growth of 155.9%; the weakest was Q2 2025, with a decline of 14.3%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $15.58 million (Q1 2026), $11.36 million (Q4 2025) and $11.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 14.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.65 Mn |
| Mar 31, 2026 | 15.58 Mn |
| Dec 31, 2025 | 11.36 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 10.46 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 6.64 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 4.23 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 4.28 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 3.84 Mn |
| Sep 30, 2021 | 3.76 Mn |
API Access
Ocular Therapeutix Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();